420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans
This week, the U.S. Food and Drug Administration (FDA) granted long-awaited approval for a clinical trial exploring whether cannabis can help manage veterans’ post-traumatic stress disorder (PTSD). The trial, which is being led by the Multidisciplinary Association for Psychedelic Studies (MAPS), has faced delays since 2021 due to various objections raised by the FDA. Concerns included the potential risks associated with smoking high-potency marijuana and the study’s dosing method, which allows participants to regulate their intake within set daily limits. MAPS said on Wednesday that the FDA had lifted its objections, allowing the study to move forward. Notably, the agency…

















